Notice: This company has been marked as potentially delisted and may not be actively trading. Invitae (NVTA) News Today Add Compare Share Share Headlines Stock AnalysisHeadlinesInsider TradesOwnershipSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Invitae Corp (OTC:NVTA) Stock, Insider Trading ActivityOctober 3, 2024 | benzinga.comInvitae Launches Unlock™ Behind the Seizure® Program for Pediatric Epilepsy PatientsJuly 22, 2024 | finance.yahoo.comInvitae's $239 million sale to Labcorp approved by Bankruptcy CourtMay 7, 2024 | bizjournals.comLabcorp to acquire Invitae in strategic dealApril 28, 2024 | msn.comLabcorp to acquire Invitae assets for $239 millionApril 26, 2024 | uk.investing.comLabcorp wins $239M bid for bankrupt InvitaeApril 26, 2024 | bizjournals.comLabcorp's Q1 Revenue Surpasses Forecasts; Analysts Scrutinize Invitae DealApril 25, 2024 | msn.comInvitae Corporation: Invitae Enters into Agreement with Labcorp for Sale of BusinessApril 25, 2024 | finanznachrichten.deLabcorp to Buy Assets of Bankrupt Invitae for $239MApril 25, 2024 | marketwatch.comClinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mlnApril 24, 2024 | reuters.comInvitae Enters into Agreement with Labcorp for Sale of BusinessApril 24, 2024 | finance.yahoo.comLabcorp Announces Winning Bid for Select Assets of InvitaeApril 24, 2024 | prnewswire.comInvitae Publishes its Environmental, Social and Governance (ESG) ReportApril 22, 2024 | tmcnet.comInvitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain SignificanceApril 11, 2024 | finance.yahoo.comInvitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain SignificanceApril 11, 2024 | prnewswire.comPioneering cancer test company wants court to slow potential sale of Invitae's cancer-monitoring productsApril 2, 2024 | bizjournals.comInvitae Launches Update to Invitae Generation™: Clinical Variant Modeling Improves Variant ClassificationMarch 12, 2024 | finance.yahoo.comNVTA.PKMarch 11, 2024 | reuters.comNVTA.NMarch 9, 2024 | reuters.comInvitae Corporation: Invitae Reports Estimated Unaudited Fourth Quarter and Full Year 2023 Financial ResultsMarch 6, 2024 | finanznachrichten.deInvitae Reports Estimated Unaudited Fourth Quarter and Full Year 2023 Financial ResultsMarch 6, 2024 | prnewswire.comInvitae to Present Data at the 2024 ACMG Annual Clinical Genetics MeetingMarch 5, 2024 | prnewswire.comNVTA Jun 2024 0.500 putMarch 3, 2024 | finance.yahoo.comNVTA Jan 2026 1.500 callFebruary 26, 2024 | finance.yahoo.comNVTA Mar 2024 0.500 putFebruary 17, 2024 | finance.yahoo.comInvitae gets court approval for five-month bankruptcy saleFebruary 15, 2024 | msn.comGenetic testing pioneer Invitae files for bankruptcy protectionFebruary 15, 2024 | bizjournals.comGenetic Test Provider Invitae (OTC:NVTA) Files for BankruptcyFebruary 14, 2024 | msn.comGenetic test maker Invitae files for bankruptcy protection in USFebruary 14, 2024 | msn.comInvitae Files for Voluntary Chapter 11 Protection; Pursues Sale ProcessFebruary 14, 2024 | finance.yahoo.comGenetic test maker Invitae files for bankruptcy protection in USFebruary 13, 2024 | reuters.comInvitae Files for Voluntary Chapter 11 Protection; Pursues Sale ProcessFebruary 13, 2024 | prnewswire.comInvitae Corp.February 9, 2024 | edition.cnn.comNVTA Stock: Invitae Plunges 78% on the Brink of BankruptcyFebruary 6, 2024 | investorplace.comNYSE to Commence Delisting Proceedings Against Invitae Corporation (NVTA)February 6, 2024 | finance.yahoo.comTrading was temporarily halted for "NVTA" at 09:02 AM with a stated reason of "News Released."February 6, 2024 | marketbeat.comInvitae Corporation: Invitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease TherapeuticsFebruary 6, 2024 | finanznachrichten.deWhy Is Invitae (NVTA) Stock Down 75% Today?February 5, 2024 | investorplace.comTrading was temporarily halted for "NVTA" at 02:02 PM with a stated reason of "News pending."February 5, 2024 | marketbeat.comMedical test maker Invitae prepares for bankruptcy - WSJFebruary 5, 2024 | reuters.comInvitae plunges amid report it may file for bankruptcy within weeksFebruary 5, 2024 | msn.comInvitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease TherapeuticsJanuary 30, 2024 | finance.yahoo.comInvitae Partners with BridgeBio Pharma to Harness Genetic Insights for the Discovery of Rare Disease TherapeuticsJanuary 30, 2024 | finance.yahoo.comInvitae cuts loose another business unit, more jobs to continue to reduce cash burnJanuary 24, 2024 | bizjournals.comNatera Acquires Reproductive Health Assets from InvitaeJanuary 22, 2024 | finance.yahoo.comNatera Acquires Assets From InvitaeJanuary 22, 2024 | markets.businessinsider.comInvitae offloads reproductive health assets to NateraJanuary 22, 2024 | msn.comInvitae Completes Sale of Reproductive Health Assets to NateraJanuary 22, 2024 | finance.yahoo.comInvitae (NYSE:NVTA) Lifted to "Hold" at StockNews.comStockNews.com raised shares of Invitae from a "sell" rating to a "hold" rating in a research report on Friday.December 29, 2023 | marketbeat.comDespite Fast-paced Momentum, Invitae (NVTA) Is Still a Bargain StockDecember 22, 2023 | finance.yahoo.com Get Invitae News Delivered to You Automatically Sign up to receive the latest news and ratings for NVTA and its competitors with MarketBeat's FREE daily newsletter. Email Address Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast. Click here for the ticker >>> NVTA Media Mentions By Week NVTA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVTA News Sentiment▼0.000.60▲Average Medical News Sentiment NVTA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVTA Articles This Week▼01▲NVTA Articles Average Week Get Invitae News Delivered to You Automatically Sign up to receive the latest news and ratings for NVTA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NTRA News LH News DGX News EXAS News RDNT News GH News VCYT News FTRE News VRDN News CDNA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NVTA) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invitae Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Invitae With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
